Effect of phosphoinositide-phospholipase c beta1 monoallelic deletion in low-risk MDS patients treated with darbepoetin.

被引：0
|
作者：
Spadaro, P.
Pitini, V.
Arrigo, C.
Ingemi, M.
机构：
[1] Casa Cura Villa Salus, Messina, Italy
[2] Univ Messina, Messina, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.6609
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6609
引用
收藏
页数：1
相关论文
共 14 条
  • [1] PHOSPHOINOSITIDE-PHOSPHOLIPASE C BETA1 AS A TARGET OF EPIGENETIC THERAPY IN MDS PATIENTS
    Follo, M.
    Finelli, C.
    Mongiorgi, S.
    Clissa, C.
    Chiarini, F.
    Bosi, C.
    Baccarani, M.
    Manzoli, L.
    Martinelli, G.
    Martelli, A.
    Cocco, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 103 - 103
  • [2] PHOSPHOINOSITIDE-PHOSPHOLIPASE C (PI-PLC) BETA1 SIGNALLING IS INVOLVED IN ERYTHROPOIETIN RESPONSE OF LOW RISK MDS PATIENTS
    Finelli, C.
    Follo, M.
    Mongiorgi, S.
    Clissa, C.
    Chiarini, F.
    Testoni, N.
    Baccarani, M.
    Manzoli, L.
    Martinelli, G.
    Martelli, A.
    Cocco, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 327 - 328
  • [3] EFFECT OF ALTERNATIVE DOSING SCHEDULES OF AZACITIDINE ON PHOSPHOINOSITIDE-PHOSPHOLIPASE C (PI-PLC) BETA1 IN HIGH RISK MDS PATIENTS
    Follo, M.
    Finelli, C.
    Mongiorgi, S.
    Clissa, C.
    Bosi, C.
    Paolini, S.
    Curti, A.
    Ramazzotti, G.
    Baccarani, M.
    Martinelli, G.
    Cocco, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 380 - 380
  • [4] Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS
    Follo, Matilde Y.
    Finelli, Carlo
    Mongiorgi, Sara
    Clissa, Cristina
    Bosi, Costanza
    Testoni, Nicoletta
    Chiarini, Francesca
    Ramazzotti, Giulia
    Baccarani, Michele
    Martelli, Alberto M.
    Manzoli, Lucia
    Martinelli, Giovanni
    Cocco, Lucio
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (39) : 16811 - 16816
  • [5] EFFECT OF AZACITIDINE AND LENALIDOMIDE THERAPY ON PHOSPHOLIPASE C BETA1 SIGNALLING IN HIGH-RISK MDS
    Follo, M. Y.
    Mongiorgi, S.
    Clissa, C.
    Stanzani, M.
    Ratti, S.
    Parisi, S.
    Barraco, M.
    De Maio, C.
    Billi, A. M.
    Manzoli, L.
    Cocco, L.
    Finelli, C.
    HAEMATOLOGICA, 2016, 101 : S61 - S62
  • [6] VALPROIC ACID AND AZACITIDINE COMBINATORIAL EFFECT ON PHOSPHOINOSITIDE-PHOSPHOLIPASE C (PI-PLC) BETA1 AND CYCLIN D3 IN HIGH RISK MYELODYSPLASTIC SYNDROMES
    Follo, M.
    Finelli, C.
    Mongiorgi, S.
    Clissa, C.
    Bosi, C.
    Chiarini, F.
    Paolini, S.
    Curti, A.
    Baccarani, M.
    Martelli, A.
    Fiume, R.
    Faenza, I.
    Martinelli, G.
    Cocco, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 377 - 377
  • [7] ASXL1 Mutations Predict a Poor Response to Darbepoetin Alfa in Anemic Patients with Low-Risk MDS: A Multicenter, Phase II Study
    Hanamoto, Hitoshi
    Morita, Yasuyoshi
    Ichikawa, Motoshi
    Nannya, Yasuhito
    Shibayama, Hirohiko
    Maeda, Yoshinobu
    Hata, Tomoko
    Miyamoto, Toshihiro
    Kawabata, Hiroshi
    Takeuchi, Kazuto
    Tanaka, Hiroko
    Kishimoto, Junji
    Miyano, Satoru
    Matsumura, Itaru
    Ogawa, Seishi
    Akashi, Koichi
    Kanakura, Yuzuru
    Mitani, Kinuko
    BLOOD, 2020, 136
  • [8] Quality of life, physical function and MRI T2*in elderly low-risk MDS patients treated to a haemoglobin level of ≥120 g/L with darbepoetin alfa ± filgrastim or erythrocyte transfusions
    Nilsson-Ehle, Herman
    Birgegard, Gunnar
    Samuelsson, Jan
    Antunovic, Petar
    Astermark, Jan
    Garelius, Hege
    Engstrom, Lena M.
    Kjeldsen, Lars
    Nilsson, Lars
    Olsson, Anna
    Skov-Holm, Mette
    Wallvik, Jonas
    Gulbrandsen, Nina
    Hellstrom-Lindberg, Eva
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 87 (03) : 244 - 252
  • [9] ESTIMATING THE CAUSAL EFFECT OF EARLY USE OF ERYTHROPOIETIC STIMULATING AGENTS IN INTERMEDIATE-1 TO LOW-RISK MDS PATIENTS: AN APPLICATION OF THE LONGITUDINAL TARGETED MAXIMUM LIKELIHOOD ESTIMATION
    Zhang, Y.
    Kreif, N.
    Gc, V
    Bennett, A.
    Manca, A.
    VALUE IN HEALTH, 2022, 25 (12) : S81 - S81
  • [10] Outcomes In RBC Transfusion-Dependent Patients (Pts) With Low-/Intermediate (Int)-1-Risk Myelodysplastic Syndromes (MDS) With Isolated Deletion 5q Treated With Lenalidomide (LEN): A Subset analysis From The MDS-004 Study
    Giagounidis, Aristoteles
    Mufti, Ghulam J.
    Mittelman, Moshe
    Sanz, Guillermo
    Platzbecker, Uwe
    Muus, Petra
    Selleslag, Dominik
    Beyne-Rauzy, Odile
    te Boekhorst, Peter
    del Canizo, Consuelo
    Guerci-Bresler, Agnes
    Luebbert, Michael
    Quesnel, Bruno
    Ganser, Arnold
    Bowen, David
    Schlegelberger, Brigitte
    Fu, Tommy
    Benettaib, Bouchra
    Hellstroem-Lindberg, Eva
    Fenaux, Pierre
    BLOOD, 2013, 122 (21)
12